From the Desk of Steve Strazza @Sstrazza

Dividend Aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing income to long-term-minded shareholders.

As you can imagine, the companies making up this prestigious list are some of the most recognizable brands in the world. Coca-Cola, Walmart, and Johnson & Johnson are just a few of the household names making the cut.

Here at All Star Charts, we like to stay ahead of the curve. That's why we're turning our attention to the future aristocrats. In an effort to seek out the next generation of the cream-of-the-crop dividend plays, we're curating a list of stocks that have raised their payouts every year for five to nine years.

We call them the Young Aristocrats, and the idea is that these are "stocks that pay you to make money." Imagine if years of consistent dividend growth and high momentum and relative strength had a baby, leaving you with the best of the emerging dividend giants that are outperforming the averages.

From the desk of Steve Strazza @Sstrazza

Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs.

We've also sprinkled in some of the largest ADRs from countries that did not make the market cap cut. 

These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.

It's got all the big names and more–but only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.

The beauty of these scans is really in their simplicity.

We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.

Based on the market environment, we can also flip the scan on its head and filter for weakness.

Let's dive in and take a look at some of the most important stocks from around the world.

Here's this week's list:

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider transaction on today’s list is a Form 4 filing by Biohaven Pharmaceutical Holding Company Ltd $BHVN director Gregory Bailey.

Bailey bought 25,503 BHVN shares, equivalent to $999,169.

You're finally seeing some of that defensive rotation with Utilities representing the only sector that is hitting new 6-month highs this week.

Here is a chart of Utilities relative to the S&P500, overlaid with Staples relative to S&Ps as well.

As you can see, both of these lines had been falling since 2022, because it's been a bull market.

But now that stocks have been correcting this year, you're seeing that outperformance coming from the most defensive sectors:

From the Desk of Steve Strazza @Sstrazza

Welcome to The Junior International Hall of Famers.

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US-listed international stocks, or ADRs.

This scan is composed of the next 100 largest stocks by market cap, those that come after the top 100 and are thus covered by the International Hall of Famers universe.

Many of these names will someday graduate and join our original International Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

Let's dive right in and check out what these future big boys are up to.

This is our Junior International Hall of Famers list:

Island Reversals are few and far between. They don't show up very often.

But when they do....look out!

Here's Meta, the parent company of Faceplant, I mean Facebook, losing a few hundred billion dollars in value since yesterday's close.

I'll say that again, "Losing a few hundred billion dollars in value"....overnight!

From the Desk of Steve Strazza and Alfonso Depablos

The only insider transaction on today’s list is a Form 4 filing by William C. Rhodes.

Rhodes reported the acquisition of 50,000 shares of Regions Financial Corporation $RF at a total cost of approximately $1 million.

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

As most of you know, we use various bottom-up tools and scans to complement our top-down approach.

It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

This is the video recording of the April 24, 2024, Hot Corner Insider Weekly Strategy Session.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list is a Form 4 filing by Atlas Venture Opportunity Fund.

The hedge fund reported the acquisition of 17,857 shares of Korro Bio Inc $KRRO, equivalent to roughly $1 million.

Stock prices don't move based on "fundamentals".

Prices move based on positioning.

When investors are primarily on one side of a market, the pendulum swings to the other extreme.

One of my heroes John Roque said it best, "We're not in a reversion TO the mean business, we're in a reversion BEYOND the mean business".

In other words, from extremes in positioning, the market doesn't just go back to the average positioning. It tends to continue towards the other extreme.

This is the situation we currently find ourselves in as investors.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list is a Form 4 filing by Cormorant Asset Management LP.

The hedge fund reported a purchase of $10.4 million in EyePoint Pharmaceuticals Inc $EYPT.